Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rotrosen

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The American Journal of Psychiatry|July 1, 1989
Dopamine blockade and clinical response: evidence for two biological subgroups of schizophreniaA Wolkin, F Barouche, A P Wolf, et al.
Psychopharmacology|January 1, 1996
Amphetamine and negative symptoms of schizophreniaM Sanfilipo, A Wolkin, B Angrist, et al.
Psychopharmacology Bulletin|January 1, 1985
The prevalence of tardive dyskinesiaJ M Kane, M Woerner, J A Lieberman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Diminished acoustic startle in chronic cocaine usersT R Efferen, E J Duncan, S Szilagyi, et al.
Archives of General Psychiatry|September 1, 1978
Thiethylperazine; clinical antipsychotic efficacy and correlation with potency in predictive systemsJ Rotrosen, B M Angrist, S Gershon, et al.
American Journal of Physiologic Imaging|January 1, 1988
Regional glucose metabolism in chronic schizophreniaJ D Brodie, A Wolkin, A P Wolf, et al.
Journal of Clinical Psychopharmacology|February 1, 1991
The prevalence of tardive dyskinesiaM G Woerner, J M Kane, J A Lieberman, et al.
Genes, Brain, and Behavior|June 4, 2008
Genetic susceptibility to heroin addiction: a candidate gene association studyO Levran, D Londono, K O'Hara, et al.
Annals of Neurology|January 1, 1984
Patterns of metabolic activity in the treatment of schizophreniaJ D Brodie, D R Christman, J F Corona, et al.
Life Sciences|June 13, 2001
Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brainJ S Fowler, N D Volkow, J Logan, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The American Journal of Psychiatry|July 1, 1989
Dopamine blockade and clinical response: evidence for two biological subgroups of schizophreniaA Wolkin, F Barouche, A P Wolf, et al.
Psychopharmacology|January 1, 1996
Amphetamine and negative symptoms of schizophreniaM Sanfilipo, A Wolkin, B Angrist, et al.
Psychopharmacology Bulletin|January 1, 1985
The prevalence of tardive dyskinesiaJ M Kane, M Woerner, J A Lieberman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Diminished acoustic startle in chronic cocaine usersT R Efferen, E J Duncan, S Szilagyi, et al.
Archives of General Psychiatry|September 1, 1978
Thiethylperazine; clinical antipsychotic efficacy and correlation with potency in predictive systemsJ Rotrosen, B M Angrist, S Gershon, et al.
American Journal of Physiologic Imaging|January 1, 1988
Regional glucose metabolism in chronic schizophreniaJ D Brodie, A Wolkin, A P Wolf, et al.
Journal of Clinical Psychopharmacology|February 1, 1991
The prevalence of tardive dyskinesiaM G Woerner, J M Kane, J A Lieberman, et al.
Genes, Brain, and Behavior|June 4, 2008
Genetic susceptibility to heroin addiction: a candidate gene association studyO Levran, D Londono, K O'Hara, et al.
Annals of Neurology|January 1, 1984
Patterns of metabolic activity in the treatment of schizophreniaJ D Brodie, D R Christman, J F Corona, et al.
Life Sciences|June 13, 2001
Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brainJ S Fowler, N D Volkow, J Logan, et al.
Pageof 13